• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疫情中断后癌症筛查重启策略的效果。

Effects of cancer screening restart strategies after COVID-19 disruption.

机构信息

Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

出版信息

Br J Cancer. 2021 Apr;124(9):1516-1523. doi: 10.1038/s41416-021-01261-9. Epub 2021 Mar 15.

DOI:10.1038/s41416-021-01261-9
PMID:33723386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957464/
Abstract

BACKGROUND

Many breast, cervical, and colorectal cancer screening programmes were disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five restart strategies after the disruption on required screening capacity and cancer burden.

METHODS

Microsimulation models simulated five restart strategies for breast, cervical, and colorectal cancer screening. The models estimated required screening capacity, cancer incidence, and cancer-specific mortality after a disruption of 6 months. The restart strategies varied in whether screens were caught up or not and, if so, immediately or delayed, and whether the upper age limit was increased.

RESULTS

The disruption in screening programmes without catch-up of missed screens led to an increase of 2.0, 0.3, and 2.5 cancer deaths per 100 000 individuals in 10 years in breast, cervical, and colorectal cancer, respectively. Immediately catching-up missed screens minimised the impact of the disruption but required a surge in screening capacity. Delaying screening, but still offering all screening rounds gave the best balance between required capacity, incidence, and mortality.

CONCLUSIONS

Strategies with the smallest loss in health effects were also the most burdensome for the screening organisations. Which strategy is preferred depends on the organisation and available capacity in a country.

摘要

背景

由于 COVID-19 大流行,许多乳腺癌、宫颈癌和结直肠癌的筛查计划被打乱。本研究旨在评估疫情中断后五种重启策略对所需筛查能力和癌症负担的影响。

方法

使用微模拟模型模拟了乳腺癌、宫颈癌和结直肠癌筛查的五种重启策略。这些模型估计了中断 6 个月后所需的筛查能力、癌症发病率和癌症特异性死亡率。重启策略的差异在于是否弥补错过的筛查以及如果弥补,是立即进行还是延迟进行,以及是否提高上限年龄。

结果

如果不弥补错过的筛查,筛查计划的中断将导致乳腺癌、宫颈癌和结直肠癌的 10 年内癌症死亡人数分别增加 2.0、0.3 和 2.5 人/每 10 万人。立即弥补错过的筛查可以将疫情中断的影响降到最低,但需要大量增加筛查能力。延迟筛查,但仍提供所有筛查轮次,在所需能力、发病率和死亡率之间取得最佳平衡。

结论

对健康影响最小的策略对筛查机构的负担也最大。选择哪种策略取决于国家的组织和可用能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/5e5805362854/41416_2021_1261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/b62baa227dc6/41416_2021_1261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/51a05956ebd7/41416_2021_1261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/5e5805362854/41416_2021_1261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/b62baa227dc6/41416_2021_1261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/51a05956ebd7/41416_2021_1261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ce/8076213/5e5805362854/41416_2021_1261_Fig3_HTML.jpg

相似文献

1
Effects of cancer screening restart strategies after COVID-19 disruption.COVID-19 疫情中断后癌症筛查重启策略的效果。
Br J Cancer. 2021 Apr;124(9):1516-1523. doi: 10.1038/s41416-021-01261-9. Epub 2021 Mar 15.
2
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.新冠疫情对澳大利亚、加拿大和荷兰基于粪便免疫化学试验的结直肠癌筛查项目的影响:一项比较建模研究。
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3.
3
[Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].[新冠疫情时代的肿瘤组织筛查项目:意大利关于累积延误、重启速度和诊断延误估计的调查]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):344-352. doi: 10.19191/EP20.5-6.S2.136.
4
Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).在疫情期间,获得乳腺癌、结直肠癌和宫颈癌筛查计划的机会不平等现象加剧了。这是伦巴第大区帕维亚医疗保健保护机构(意大利北部)进行的一项公平性健康审计的结果。
Epidemiol Prev. 2024 Mar-Apr;48(2):130-139. doi: 10.19191/EP24.2.A672.040.
5
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.美国癌症筛查不足与新冠疫情的关联。
JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884.
6
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.在结直肠癌筛查计划中优先考虑结肠镜检查服务,以最大程度减少 COVID-19 大流行对预测癌症负担的影响:一项比较建模研究。
J Med Screen. 2022 Jun;29(2):72-83. doi: 10.1177/09691413211056777. Epub 2021 Dec 3.
7
Recovering cancer screening in the pandemic: strategies and their impacts.大流行期间恢复癌症筛查:策略及其影响。
Br J Cancer. 2021 Apr;124(9):1465-1466. doi: 10.1038/s41416-021-01264-6. Epub 2021 Mar 15.
8
A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.基于模型的澳大利亚 COVID-19 对乳腺癌、肠癌和宫颈癌筛查项目影响的评估。
Elife. 2023 Apr 6;12:e82818. doi: 10.7554/eLife.82818.
9
The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.COVID-19 对韩国结直肠癌、胃癌、乳腺癌和宫颈癌筛查的影响。
Epidemiol Health. 2022;44:e2022053. doi: 10.4178/epih.e2022053. Epub 2022 Jun 21.
10
Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.考察加拿大曼尼托巴省 COVID-19 大流行与乳腺癌、宫颈癌和结直肠癌诊断检测率之间的关联。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241263616. doi: 10.1177/15330338241263616.

引用本文的文献

1
Impact of the COVID-19 pandemic on the Andalusian program for early detection of diabetic retinopathy: a population-based study.2019年冠状病毒病大流行对安达卢西亚糖尿病视网膜病变早期检测项目的影响:一项基于人群的研究。
Front Clin Diabetes Healthc. 2025 Aug 14;6:1631252. doi: 10.3389/fcdhc.2025.1631252. eCollection 2025.
2
Initial and persistent changes in cancer screening in a US Midwestern community health center network following the onset of COVID-19.美国中西部社区卫生中心网络在新冠疫情爆发后癌症筛查的初始及持续变化
Prev Med Rep. 2025 Mar 18;53:103030. doi: 10.1016/j.pmedr.2025.103030. eCollection 2025 May.
3

本文引用的文献

1
The impact of the COVID-19 pandemic on cancer care.新冠疫情对癌症护理的影响。
Nat Cancer. 2020 Jun;1(6):565-567. doi: 10.1038/s43018-020-0074-y.
2
COVID-19 and cancer.新型冠状病毒肺炎与癌症。
Science. 2020 Jun 19;368(6497):1290. doi: 10.1126/science.abd3377.
3
Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care.2019冠状病毒病大流行对癌症症状诊断的影响:基层医疗视角
Healthcare access, attitudes and behaviours among Navajo adults during the COVID-19 pandemic: a cross-sectional study.
新冠疫情期间纳瓦霍族成年人的医疗保健可及性、态度及行为:一项横断面研究
BMJ Public Health. 2024 Jul;2(1). doi: 10.1136/bmjph-2023-000061. Epub 2024 Mar 18.
4
The impact of the COVID-19 pandemic on clinical practices related to colorectal cancer and colonoscopy in South Korea: a nationwide population-based study.新冠疫情对韩国结直肠癌及结肠镜检查相关临床实践的影响:一项基于全国人口的研究
Intest Res. 2025 Jan;23(1):85-95. doi: 10.5217/ir.2024.00066. Epub 2024 Nov 29.
5
Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic.2019冠状病毒病大流行期间宫颈癌管理中遇到的机遇与挑战。
Infect Agent Cancer. 2024 Aug 29;19(1):41. doi: 10.1186/s13027-024-00594-3.
6
Evidence-informed decision-making in public health in Canada: a qualitative exploration.加拿大公共卫生领域基于证据的决策制定:一项定性探索
JBI Evid Implement. 2025 Jan 1;23(1):103-118. doi: 10.1097/XEB.0000000000000454.
7
Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.SARS-CoV-2 大流行对宫颈癌及癌前病变诊断的影响:一项单中心回顾性研究。
Medicina (Kaunas). 2024 May 30;60(6):909. doi: 10.3390/medicina60060909.
8
Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.2019年冠状病毒病疫情对加泰罗尼亚宫颈癌筛查参与率、异常细胞学患病率及筛查间隔的影响
Front Oncol. 2024 May 29;14:1338859. doi: 10.3389/fonc.2024.1338859. eCollection 2024.
9
Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.种族和民族的医疗保健机会和预防性健康筛查的变化。
JAMA Health Forum. 2024 Feb 2;5(2):e235058. doi: 10.1001/jamahealthforum.2023.5058.
10
Cancer Screening Disparities Before and After the COVID-19 Pandemic.癌症筛查在新冠疫情前后的差异。
JAMA Netw Open. 2023 Nov 1;6(11):e2343796. doi: 10.1001/jamanetworkopen.2023.43796.
Lancet Oncol. 2020 Jun;21(6):748-750. doi: 10.1016/S1470-2045(20)30242-4. Epub 2020 Apr 30.
4
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.荷兰在新冠疫情期间癌症诊断病例减少。
Lancet Oncol. 2020 Jun;21(6):750-751. doi: 10.1016/S1470-2045(20)30265-5. Epub 2020 Apr 30.
5
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review.欧洲有组织的宫颈癌筛查对宫颈癌死亡率的影响:系统评价。
Eur J Cancer. 2020 Mar;127:207-223. doi: 10.1016/j.ejca.2019.12.013. Epub 2020 Jan 21.
6
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.结直肠癌筛查对欧洲癌症特异性死亡率的影响:系统评价。
Eur J Cancer. 2020 Mar;127:224-235. doi: 10.1016/j.ejca.2019.12.014. Epub 2020 Jan 10.
7
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.欧洲乳腺癌筛查降低癌症特异性死亡率的证据:系统评价。
Eur J Cancer. 2020 Mar;127:191-206. doi: 10.1016/j.ejca.2019.12.010. Epub 2020 Jan 10.
8
Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.荷兰宫颈癌筛查项目中采用高危型 HPV DNA 检测进行初筛:一项基于人群的队列研究。
BMC Med. 2019 Dec 11;17(1):228. doi: 10.1186/s12916-019-1460-0.
9
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST).利用有效的筛查工具(BEST)识别 31 个欧洲国家在乳腺癌、宫颈癌和结直肠癌筛查方面存在的障碍。
Health Policy. 2018 Nov;122(11):1190-1197. doi: 10.1016/j.healthpol.2018.08.004. Epub 2018 Aug 27.
10
Colorectal Cancer: Cost-effectiveness of Colonoscopy versus CT Colonography Screening with Participation Rates and Costs.结直肠癌:基于参与率和成本的结肠镜检查与 CT 结肠成像筛查的成本效益比较。
Radiology. 2018 Jun;287(3):901-911. doi: 10.1148/radiol.2017162359. Epub 2018 Feb 27.